CLINICAL_TRIALS
ClinicalTrials.gov record update
68Ga PSMA-11 in Patients With Intermediate to High-risk Prostate Cancer Before Prostatectomy or With Biochemical Recurrence of Prostate Cancer.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04452136
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:45.447163+00:00
- Published At
- 2022-03-14T00:00:00+00:00
- Record Updated At
- 2022-03-14
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Prostatic Neoplasms", "Prostatic Diseases", "Prostate Cancer", "Prostate Cancer Metastatic", "Prostate Cancer Recurrent"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-14"- protocolSection.identificationModule.nctId
"NCT04452136"- protocolSection.identificationModule.officialTitle
"68Ga PSMA-11 in Patients With Intermediate to High-risk Prostate Cancer Before Prostatectomy or With Biochemical Recurrence of Prostate Cancer."- protocolSection.statusModule.overallStatus
"APPROVED_FOR_MARKETING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.